drugset / Trial / NCT05156814
Comparative Study to Evaluate the Efficacy and Safety of the Fixed-dose Combination of Estradiol / Dydrogesterone in Perimenopausal Women
RandomizedParallel-groupOpen-labelTreatment
Summary
To obtain new data allowing personalizing continuous hormonal therapy in perimenopausal women in Russia, the following clinical study is going to be conducted in the Russian Federation:
Timeline
- Start
- 2021-11-29
- Primary completion
- 2022-09
- Completion
- 2023-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cimicifuga racemosa rhizomatum extract | Unknown | — | — |
| Subject | Dydrogesterone | Other / unclassified | 10 mg | — |
| Subject | Estradiol | Other / unclassified | 0.1 % | Topical |
| Subject | Estradiol | Other / unclassified | 1 mg | Topical |
| Subject | Estradiol | Other / unclassified | 2 mg | Topical |
Indications
No indication recorded.